SONN   $5.91  -4.52% Market Closed After Close 6.0 1.52%

Sonnet Biotherapeutics Holdings Inc
Total Cash 3.55M
totalCashPerShare 5.466
EBITDA -12.26M
Total Debt 150.19K
quickRatio 1.31
currentRatio 1.649
Total Revenue 55.88K
debtToEquity 5.736
Revenue/Share 0.118
ROA -0.96928
ROE -2.64567
grossProfits
freeCashflow -9.88M
operatingCashflow -10.00M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -219.68546
profitMargins 0.0
enterpriseValue -256.63K
forwardPE -0.3382353
floatShares 558.31K
sharesOutstanding 650.31K
sharesShort 12.92K
sharesShortPriorMonth 5.55K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.05%
heldPercentInstitutions 0.14%
Short Ratio help_outline 0.99%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 4.014
Price To Book help_outline 1.26
earningsQuarterlyGrowth
netIncomeToCommon -7.99M
trailingEps -0.96%
forwardEps -14.96%
enterpriseToEbitda 0.02
lastDividendValue
lastDividendDate
currentQuarterEstimate -5.04 3Q 2024
institutionsCount 11
lastUpdated Oct. 16, 2024, 9:45 p.m.